OrbiMed’s Trevi Therapeutics TRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.1M Buy
3,308,400
+2,188,400
+195% +$12M 0.45% 45
2025
Q1
$7.04M Buy
+1,120,000
New +$7.04M 0.17% 71